Walleye Capital
RMD icon

Walleye Capital’s ResMed RMD Stock Holding History

Walleye Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6M Buy
84,945
+81,656
+2,483% +$16.9M 0.06% 294
2026
Q1 		$738K Buy
+3,289
New +$820K ﹤0.01% 2350
2025
Q4 		– Sell
-6,415
Closed -$1.64M – 5025
2025
Q3 		$1.76M Buy
6,415
+3,160
+97% +$863K 0.01% 1674
2025
Q2 		$840K Sell
3,255
-196
-6% -$46.8K ﹤0.01% 2188
2025
Q1 		$773K Buy
3,451
+2,891
+516% +$675K ﹤0.01% 2199
2024
Q4 		$128K Sell
560
-25,850
-98% -$6.22M ﹤0.01% 4013
2024
Q3 		$6.45M Buy
+26,410
New +$5.9M 0.01% 989
2024
Q2 		– Sell
-1,100
Closed -$223K – 5938
2024
Q1 		$218K Buy
+1,100
New +$202K ﹤0.01% 3923
2023
Q3 		– Sell
-637
Closed -$115K – 5255
2023
Q2 		$139K Sell
637
-695
-52% -$155K ﹤0.01% 3287
2023
Q1 		$292K Buy
1,332
+145
+12% +$31.5K ﹤0.01% 2150
2022
Q4 		$247K Buy
+1,187
New +$261K ﹤0.01% 1911
2019
Q3 		– Sell
-406
Closed -$53.2K – 2203
2019
Q2 		$50K Buy
+406
New +$45K 0.01% 1383

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Walleye Capital's RMD Position: Q2 2026 in Review

Walleye Capital increased its ResMed (RMD) stake by 2,483% in Q2 2026, buying an estimated $16.9M and bringing the position to 84,945 shares worth $16.6M. The position accounts for 0.06% of the portfolio, ranked #294.

Walleye Capital first reported a position in RMD in Q2 2019 and has held it in 12 quarters since. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Walleye Capital held 84,945 shares of ResMed worth $16.6M as of Q2 2026.
  • Walleye Capital bought 81,656 ResMed shares in Q2 2026, an estimated $16.9M.
  • ResMed made up 0.06% of Walleye Capital's portfolio in Q2 2026, its #294 holding.
  • Walleye Capital first reported a position in ResMed in Q2 2019 and has held it in 12 quarters since.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.